deltatrials
Recruiting OBSERVATIONAL NCT06813443

Characterization of Patients With Cardiomyopathy to Identify Critical Patients Candidates for Cardiac Transplantation (CMPMIRNA)

Clinical, Instrumental, and Molecular (Circulating and Tissue microRNAs) Characterization of Patients With Cardiomyopathy to Identify Critical Patients With Severe Organ Failure to be Candidates for Cardiac Transplantation

Sponsor: IRCCS Azienda Ospedaliero-Universitaria di Bologna

Conditions Amyloidosis Cardiac Arrhythmogenic Cardiomyopathy Cardiac Magnetic Resonance Imaging Cardiomyopathies Dilated Cardiomyopathy Dystrophia Myotonica Echocardiogram Electrocardiogram Fabry Disease Glycogen Storage Disease Heart Transplantation Hypertrophic Cardiomyopathy (HCM) Infiltrative Cardiomyopathy Laminopathies Micro RNA Mitochondrial Cardiomyopathy Sudden Cardiac Death
Updated 2 times since 2025 Last updated: Feb 3, 2025 Started: Feb 13, 2023 Primary completion: Jun 30, 2027 Completion: Dec 14, 2027
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT06813443, this observational or N/A phase trial focuses on Amyloidosis Cardiac and Arrhythmogenic Cardiomyopathy and remains actively recruiting participants. Sponsored by IRCCS Azienda Ospedaliero-Universitaria di Bologna, it has been updated 2 times since 2023, reflecting limited change activity. This study contributes longitudinal data to the cardiovascular research landscape.

Status Flow

~Mar 2025 – ~Sep 2025 · 6 months · monthly snapshotRecruiting~Sep 2025 – present · 10 months · monthly snapshotRecruiting

Change History

2 versions recorded

  1. Sep 2025 — Present [monthly]

    Recruiting

  2. Mar 2025 — Sep 2025 [monthly]

    Recruiting

    First recorded

Feb 2023

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • IRCCS Azienda Ospedaliero-Universitaria di Bologna
Data source: IRCCS Azienda Ospedaliero-Universitaria di Bologna

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations